**Safety Study of RO7669330 for Eye Condition** This study is testing a new medication called **RO7669330** for people with a specific eye condition called **geographic atrophy (GA)**, which is linked to age-related macular degeneration (**AMD**). GA is a disease that damages the retina, the part of the eye that helps us see. This study will check how safe and tolerable the medicine is when given as an eye injection (intravitreal injection). The study will also check how the body processes the drug (pharmacokinetics) and how the drug affects the body (pharmacodynamics). Participants will need clear eye scans and will be observed for changes in their ability to see. The study excludes people who have had certain eye surgeries or treatments before. Participants must not have other eye diseases that could affect the study results. - **Study Duration:** Multiple visits for injections and eye tests over a period of time. - **Eligibility:** Must have GA due to AMD and meet specific vision requirements. - **Risks:** Eye injections and possible side effects, but monitored by doctors. **

Note:** Participation involves time commitment and medical checks.

**